Unpacking Drug Pricing with Real-World Evidence Dataset

<p dir="ltr">Overview This project explores the pricing landscape of high-cost cancer medications using real-world healthcare data (RWE), including insurance claims, electronic medical records (EMRs), prescription rates, and public reimbursement records. The goal is to analyze cost patterns, treatment delays, and prescribing behaviors to generate actionable insights for patients, payers, policymakers, and healthcare providers.</p>